secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2021-08-05T23:59:59+00:00
Accession:  0001564590-21-041598
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical Q2 revenue up 115% to $25.2M; raises FY2021 guidance to $97-100M; names Nabeel Ahmed permanent CFO
--------------------------------------------------------------------------------

- Revenue $25.2M, +115% YoY; product revenue $20.6M (+113%).
- Gross margin improved to 4.2% from (40.6%) in prior year; product gross margin (7.0%) vs (57.7%).
- Full-year 2021 revenue guidance raised to $97-100M from $92-97M, representing ~94-100% YoY growth.
- Net loss of ($30.2M) or ($0.66) per share; non-GAAP net loss ($26.3M) or ($0.57) per share.
- Nabeel Ahmed appointed permanent CFO effective July 30, 2021; salary increased to $385K and equity awards granted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000156459021041598/0001564590-21-041598-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000156459021041598/om-8k_20210730.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-041598

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer